Straits Times Index
3,084.08 -6.23 (-0.20%) S&P 500
4,569.78 -24.85 (-0.54%) Dow
36,204.44 -41.06 (-0.11%) Nasdaq
14,185.49 -119.54 (-0.84%) Bitcoin USD
41,906.75 +1,830.43 (+4.57%) CMC Crypto 200
860.54 +1.83 (+0.21%)
Becton, Dickinson and Company (BDX)
After hours:
| Previous close | 238.25 |
| Open | 237.32 |
| Bid | 233.00 x 1000 |
| Ask | 242.22 x 800 |
| Day's range | 237.10 - 238.56 |
| 52-week range | 228.62 - 287.32 |
| Volume | |
| Avg. volume | 1,365,609 |
| Market cap | 68.992B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 46.58 |
| EPS (TTM) | 5.10 |
| Earnings date | 31 Jan 2024 - 05 Feb 2024 |
| Forward dividend & yield | 3.80 (1.59%) |
| Ex-dividend date | 07 Dec 2023 |
| 1y target est | 282.00 |
- PR Newswire
BD to Present Next Installment of BD Innovates Series: Spotlight on Pharmaceutical Systems
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present the next installment of its BD Innovates series, which will highlight its Pharmaceutical Systems business on Monday, December 11, 2023, at 11:30 am Eastern Time. The BD Innovates series spotlights BD's innovation, products and pipeline in support of its BD 2025 Strategy.
Simply Wall St.Just Four Days Till Becton, Dickinson and Company (NYSE:BDX) Will Be Trading Ex-Dividend
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
- Reuters
UPDATE 2-US FDA says BD recalling infusion pumps due to compatibility issues
The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson is recalling its Alaris infusion pumps due to compatibility issues with Cardinal Health's Monoject syringes. The health regulator said Alaris pumps are validated for use with Monoject syringes.
